This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.
Read MoreAs the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially ICH.
Read MoreThis program covers management of life-threatening bleeding of anticoagulated patients and the use of reversal/repletion agents in critical access hospitals.
Read MoreAs the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies.
Read MoreThe current approach and disease indications for treatment with anticoagulants such as coumadin, Factor IIa, and Factor Xa inhibitors are particularly relevant. This program is highlighted by the presentation of cases managed by experts in emergency medicine, critical care medicine, hospital medicine, and trauma surgery.
Read MoreJoin Natalie Kreitzer, MD, MS, take you through a step-by-step approach to managing this life-threatening condition in your ED.
Read MoreThrough this critical care approach to the evaluation and treatment of life-threatening bleeding in anti-coagulated patients, clinicians caring for these patients in the acute care setting (ED and ICU) will be better prepared to manage them.
Read MoreSubscribe for complimentary material and announcements.
